An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested...

The European Commission (EC) has approved blinatumomab monotherapy as consolidation therapy for treating adult patients with newly diagnosed...

A discovery at Duke-NUS Medical School offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively...

Researchers have discovered that mitochondrial dysfunction plays a crucial role in diabetes, offering new hope for potential treatments.

AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, paving the way for future...

Cardiac arrhythmias affect millions across the world and are responsible for a fifth of all deaths in the Netherlands.

The WA Adult Cystic Fibrosis Centre, run out of Sir Charles Gairdner Hospital, opened in 1978 when the average life expectancy was just 11 years old.

A groundbreaking study by researchers at Wuhan University, China, has identified a cholesterol metabolite that plays a crucial role in the progression...

A phase 2 non-randomised clinical trial has demonstrated the potential benefits of pembrolizumab in patients with advanced clear cell gynaecological...

Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome (communities of bacteria) of...